PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
Volume 15 Issue 3

5 Steps to Improving Pharmacovigilance System Master File (PSMF) Management

Christian Schmitz-Moormann, a senior consultant and pharmacovigilance (PV) expert, and partner of Generis, considers the role of this essential master resource in ma...
Continue Reading →
Volume 15 Issue 3

Why Pharma Dealmaking is a Sector that’s Ripe for Growth

The global pharmaceutical sector is booming thanks to continued growth in R&D spend in new technologies and therapeutic areas, putting the industry back on a mor...
Continue Reading →
News

Aragen expects to ride wave of US biotech growth in 2022 – influx of discovery capital is surging demand for CDMO services

Company plans wide-ranging investments and expansions to keep pace with demand driven by macro-changes and diversifying client base Aragen Life Sciences (for...
Continue Reading →
News

Symcel appoints two new board members to bolster R&D business growth and expansion into the clinical diagnostics market

Symcel – the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, the calScreener™ – has announced the appointment of t...
Continue Reading →
News

WuXi STA to build new R&D center in Shanghai

STA Pharmaceutical Co., Ltd., a subsidiary of WuXi AppTec (WuXi STA), announces that it has signed an investment agreement with the government of Shanghai, Jinsh...
Continue Reading →
News

Standardization of R&D Outsourcing Becomes a Clinical Research Reality

Bold steps have been announced today about the standardization in the approach to R&D Outsourcing. IAOCR and the Pharmaceutical Contract Management Group (PCMG),...
Continue Reading →
News

SYGNIS AG Installs Scalable Production Capability for Lightning-Link Antibody Conjugation Technology

SYGNIS AG (Frankfurt: LIO1; ISIN: DE000A1RFM03; Prime Standard), the Group which includes Expedeon Holdings, Innova Biosciences, and C.B.S. Scientific Company, today...
Continue Reading →
News

With UK Pharma facing Brexit headwinds, could UK Gov't defeat help industry by leading to a “softer” Brexit? asks GlobalData

The UK Government’s narrow defeat (Wednesday 13th November) on amendment seven of the European Union withdrawal bill, demanding that Parliament have a binding vote ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026